Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20191022045196N1
IRCT20191022045196N1
Recruiting
Phase 2

Evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial

Shahid Beheshti University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Status
Recruiting
Enrollment
40
OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
17 years to no limit (—)
Sex
All

Inclusion Criteria

  • •Man and woman over 17 years old
  • •Patient with Parkinson's disease according to UKPDSBB criteria
  • •Provide written informed consent to participate in the study
  • •Understand that they may withdraw their consent at any time.

Exclusion Criteria

  • •1\. Pregnant and lactating women
  • •2\. Patients with diabetes and taking anti\-hyperglycemic drugs
  • •3\. Other neurodegenerative diseases like multiple system atrophy, Huntington's, Wilson's disease, Alzheimer's, ALS, progressive supranuclear palsy, etc.
  • •4\. Patients who cannot walk for more than one minute without help.
  • •5\. Patients with history of allergic reactions to insulin
  • •6\. Patients with history of nasal cavity inflammation that prevents insulin absorption
  • •7\. Patients with kidney and liver diseases

Investigators

Similar Trials

Recruiting
Phase 3
Efficacy trial of intranasal insuliElective cardiac surgery requiring cardiopulmonary bypassvalvular diseases, Ischemic heart diseases
JPRN-jRCTs031230047akadate Yosuke110
Completed
Not Applicable
Effect of intranasal insulin administering on patients with loss of smell
IRCT2017061712782N15Vice chancellor for research,Isfahan University of Medical Sciences36
Completed
Phase 2
SNIFF 120: Study of Nasal Insulin to Fight Forgetfulness (120 Days)Mild Cognitive ImpairmentAlzheimer's Disease
NCT00438568University of Washington173
Completed
Phase 2
The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndrome
NL-OMON37136niversitair Medisch Centrum Groningen20
Active, not recruiting
Not Applicable
The effect of insulin nasal spray on development and behaviour of children with Phelan-McDermid syndromePhelan-McDermid syndromeTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2012-002873-77-NLniversity Medical Center Groningen, Department of Genetics